AutoMedica Ltd

Based in the UK, AutoMedica Ltd develops advanced healthcare AI solutions to enhance clinical practices and patient interactions, particularly in the provision of evidence-based insights and streamlined communication. AutoMedica Ltd specializes in innovative healthcare AI solutions. Founded in 2024 in High Wycombe, UK, the company has completed one deal as of February 2026, when it was acquired by Heidi Health Trading Pty Limited. The founder's history is not specified, and there have been no reported pivots in business strategy.

AutoMedica Ltd, now part of Heidi Health, specializes in developing innovative healthcare AI solutions aimed at enhancing clinical practices and patient communications. Its core offerings include Heidi Evidence, which provides evidence-based insights for clinicians, and Heidi Comms, an AI-driven tool designed to streamline patient interactions by managing calls, bookings, reminders, and follow-ups. These products are tailored to support healthcare teams in improving operational efficiency and patient engagement, thus addressing the challenges of communication in clinical settings. The suite of solutions is primarily targeted at healthcare providers within the UK, although the potential for expansion into other markets exists as the platform matures and integrates with varying healthcare infrastructures globally.

AutoMedica's revenue model is structured around partnerships and subscription-based services, facilitating transactions with healthcare institutions and providers. Clients, including hospitals and clinics, engage with the platform through various subscription plans designed to cater to different scales of operation, from small practices to large healthcare networks. The company’s flagship offerings, such as Heidi Evidence and Heidi Comms, operate on a tiered pricing structure that corresponds to the level of service and support provided. By leveraging a direct-to-consumer approach, AutoMedica ensures that its AI solutions are accessible to a broad range of end-users in the healthcare sector, thereby fostering a sustainable revenue stream aligned with the demand for advanced clinical AI systems.

In February 2026, AutoMedica was acquired by Heidi Health Trading Pty Limited, which aims to broaden its presence in the British market and support its regulatory alignment initiatives. The acquisition is expected to facilitate the design and launch of new products, although specific launch dates are not provided. Future expansion plans include targeting additional geographical markets as the platform develops further to integrate with various healthcare infrastructures globally.